He lost his insurance and turned to a cheaper form of insulin. It was a fatal decision.
His death at age 27 illustrates the worst-case scenario for thousands of lower-income people living with diabetes in the United States who depend on over-the-counter insulin that — for $25 a vial at Walmart — sells for one-tenth of what the more effective version costs.
The skyrocketing price of insulin — which emulates the hormone secreted by the pancreas to regulate glucose in the blood — has stirred widespread outrage in the United States, amid reports of people dying after rationing the medication, begging online for help with costs or venturing out of the country in search of better deals.
Last week, the Trump administration announced steps to allow states to import lower-priced medication from Canada — a plan that could include insulin, officials said. A few days earlier, Sen. Bernie Sanders (I-Vt.) joined a group of people with Type 1 diabetes on a bus from Detroit to Windsor, Ontario, where they found insulin sold for a tiny fraction of what it costs in the United States.